Biotechnology in drug delivery represents a revolutionary field that harnesses biological processes and techniques to enhance the targeted and efficient delivery of pharmaceutical compounds. This cutting-edge approach seeks to overcome traditional challenges in drug delivery, such as limited specificity and potential side effects. Through the integration of biotechnological tools, researchers can design advanced drug delivery systems that optimize therapeutic outcomes while minimizing adverse effects. One key aspect of biotechnology in drug delivery involves the development of innovative drug carriers, often utilizing biomaterials or nanoparticles. These carriers can be engineered to encapsulate drugs, protecting them from degradation and facilitating their release at specific sites within the body. Furthermore, biotechnological advancements enable the customization of drug delivery systems based on the unique characteristics of diseases or individual patients. Biotechnology also plays a crucial role in designing drug formulations that respond dynamically to physiological changes. Smart drug delivery systems, guided by biological signals, allow for on-demand release of therapeutic agents, maximizing efficacy while minimizing systemic exposure. This level of precision is particularly valuable in the treatment of complex diseases, including cancers and chronic conditions. Moreover, biotechnological interventions contribute to the development of personalized medicine approaches. By leveraging genetic information and molecular targeting, drug delivery systems can be tailored to the genetic makeup of patients, increasing treatment effectiveness and reducing the risk of adverse reactions. In conclusion, biotechnology in drug delivery is revolutionizing the pharmaceutical landscape by offering solutions that enhance drug efficacy, minimize side effects, and pave the way for personalized therapeutic interventions. As this field continues to evolve, it holds the promise of transforming the way we approach and administer treatments, ultimately improving patient outcomes and quality of life.
Title : Renewed novel biotech ideas, with bioreactor bioengineering economic impact
Murray Moo Young, University of Waterloo, Canada
Title : Improving health in over 40,000 patients: The impact of nanomedicine fighting antibiotic resistant infections
Thomas J Webster, Brown University, United States
Title : Osmotic lysis–driven Extracellular Vesicle (EV) engineering
Limongi Tania, University of Turin, Italy
Title : Evaluating cell compatibility and subcutaneous host response of silk fibroin–chitosan plug composites as potential resorbable implants
Luis Jesus Villarreal Gomez, Universidad Autonoma de Baja California, Mexico
Title : Comparative study of endo-?-1,4-mannanases from novel bacterial strains for the production of galactomanno-oligosaccharides
Shruti Saini, National Agri-food and Bio-manufacturing Institute, India
Title : Engineering Sf9 host cells with AcMNPV genes to control baculovirus infection dynamics and heterologous gene expression
Tamer Z Salem, Zewail City of Science and Technology, Egypt